EPHA2 OVEREXPRESSION

Clinical trials for EPHA2 OVEREXPRESSION explained in plain language.

Never miss a new study

Get alerted when new EPHA2 OVEREXPRESSION trials appear

Sign up with your email to follow new studies for EPHA2 OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test 'Living Vaccine' that trains immune system to hunt cancer

Disease control Ongoing

This early-stage trial is testing a personalized cancer vaccine made from a patient's own immune cells. The cells are engineered to target two specific markers found on some advanced solid tumors. The vaccine is given alongside standard immunotherapy drugs to see if it's safe and…

Matched conditions: EPHA2 OVEREXPRESSION

Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

EPHA2 OVEREXPRESSION

Get alerted when new EPHA2 OVEREXPRESSION trials appear

Scientists test 'Living Vaccine' that trains immune system to hunt cancer